Terms: = Brain cancer AND NF1, NFNS, 4763, ENSG00000196712, P21359 AND Treatment
184 results:
1. STING activation reprograms the microenvironment to sensitize nf1-related malignant peripheral nerve sheath tumors for immunotherapy.
Somatilaka BN; Madana L; Sadek A; Chen Z; Chandrasekaran S; McKay RM; Le LQ
J Clin Invest; 2024 Mar; 134(10):. PubMed ID: 38502231
[TBL] [Abstract] [Full Text] [Related]
2. Genetically Distinct Oligosarcoma Arising from Oligodendroglioma: Systematic Review & Illustrative Case Example.
Evans AR; Prather KY; Battiste J; Fung KM; Dunn IF; Graffeo CS
World Neurosurg; 2024 May; 185():e1093-e1100. PubMed ID: 38490447
[TBL] [Abstract] [Full Text] [Related]
3. Impact of trametinib on the neuropsychological profile of nf1 patients.
Lalancette E; Cantin É; Routhier MÈ; Mailloux C; Bertrand MC; Kiaei DS; Larouche V; Tabori U; Hawkins C; Ellezam B; Décarie JC; Théoret Y; Métras MÉ; McKeown T; Ospina LH; Vairy S; Ramaswamy V; Coltin H; Sultan S; Legault G; Bouffet É; Lafay-Cousin L; Hukin J; Erker C; Caru M; Dehaes M; Jabado N; Perreault S; Lippé S
J Neurooncol; 2024 May; 167(3):447-454. PubMed ID: 38443693
[TBL] [Abstract] [Full Text] [Related]
4. nSEA: n-Node Subnetwork Enumeration Algorithm Identifies Lower Grade Glioma Subtypes with Altered Subnetworks and Distinct Prognostics.
Zhang Z; Wang C; Zhao Z; Yi Z; Durmaz A; Yu JS; Bebek G
Pac Symp Biocomput; 2024; 29():521-533. PubMed ID: 38160304
[TBL] [Abstract] [Full Text] [Related]
5. Econazole selectively induces cell death in nf1-homozygous mutant tumor cells.
Lakes YB; Moye SL; Mo J; Tegtmeyer M; Nehme R; Charlton M; Salinas G; McKay RM; Eggan K; Le LQ
Cell Rep Med; 2023 Dec; 4(12):101309. PubMed ID: 38086379
[TBL] [Abstract] [Full Text] [Related]
6. "De novo replication repair deficient glioblastoma, IDH-wildtype" is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockade.
Hadad S; Gupta R; Oberheim Bush NA; Taylor JW; Villanueva-Meyer JE; Young JS; Wu J; Ravindranathan A; Zhang Y; Warrier G; McCoy L; Shai A; Pekmezci M; Perry A; Bollen AW; Phillips JJ; Braunstein SE; Raleigh DR; Theodosopoulos P; Aghi MK; Chang EF; Hervey-Jumper SL; Costello JF; de Groot J; Butowski NA; Clarke JL; Chang SM; Berger MS; Molinaro AM; Solomon DA
Acta Neuropathol; 2023 Dec; 147(1):3. PubMed ID: 38079020
[TBL] [Abstract] [Full Text] [Related]
7. Neurofibromatosis type 1 mosaicism in patients with constitutional mismatch repair deficiency.
Guerrini-Rousseau L; Pasmant E; Muleris M; Abbou S; Adam-De-Beaumais T; Brugieres L; Cabaret O; Colas C; Cotteret S; Decq P; Dufour C; Guillerm E; Rouleau E; Varlet P; Zili S; Vidaud D; Grill J
J Med Genet; 2024 Jan; 61(2):158-162. PubMed ID: 37775264
[TBL] [Abstract] [Full Text] [Related]
8. Molecular Features of Resected Melanoma brain Metastases, Clinical Outcomes, and Responses to Immunotherapy.
Vasudevan HN; Delley C; Chen WC; Mirchia K; Pan S; Shukla P; Aabedi AA; Nguyen MP; Morshed RA; Young JS; Boreta L; Fogh SE; Nakamura JL; Theodosopoulos PV; Phillips J; Hervey-Jumper SL; Daras M; Pike L; Aghi MK; Tsai K; Raleigh DR; Braunstein SE; Abate AR
JAMA Netw Open; 2023 Aug; 6(8):e2329186. PubMed ID: 37589977
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial.
Kessler T; Schrimpf D; Doerner L; Hai L; Kaulen LD; Ito J; van den Bent M; Taphoorn M; Brandes AA; Idbaih A; Dômont J; Clement PM; Campone M; Bendszus M; von Deimling A; Sahm F; Platten M; Wick W; Wick A
Clin Cancer Res; 2023 Oct; 29(19):3892-3900. PubMed ID: 37494539
[TBL] [Abstract] [Full Text] [Related]
10. Other Nerve Sheath Tumors of brain and Spinal Cord.
Petrov M; Sakelarova T; Gerganov V
Adv Exp Med Biol; 2023; 1405():363-376. PubMed ID: 37452945
[TBL] [Abstract] [Full Text] [Related]
11. Cutaneous Neurofibroma Heterogeneity: Factors that Influence Tumor Burden in Neurofibromatosis Type 1.
Jiang C; McKay RM; Lee SY; Romo CG; Blakeley JO; Haniffa M; Serra E; Steensma MR; Largaespada D; Le LQ
J Invest Dermatol; 2023 Aug; 143(8):1369-1377. PubMed ID: 37318402
[TBL] [Abstract] [Full Text] [Related]
12. Neurosurgical morbidity in pediatric supratentorial midline low-grade glioma: Results from the German LGG studies.
Weiß S; Thomale UW; Schulz M; Kandels D; Schuhmann MU; El Damaty A; Krauss J; Driever PH; Witt O; Bison B; Pietsch T; Gnekow A; Simon M
Int J Cancer; 2023 Oct; 153(8):1487-1500. PubMed ID: 37260252
[TBL] [Abstract] [Full Text] [Related]
13. Establishment and characterization of two novel patient-derived lines from canine high-grade glioma.
Schrock MS; Zalenski AA; Tallman MM; Kollin L; Bratasz A; Weeks G; Miller MA; Sweeney CN; Pluhar GE; Olin MR; Kisseberth WC; Bentley RT; Dickinson PJ; York D; Webb A; Wang X; Moore S; Venere M; Summers MK
Vet Comp Oncol; 2023 Sep; 21(3):492-502. PubMed ID: 37254642
[TBL] [Abstract] [Full Text] [Related]
14. Basement membrane proteins in extracellular matrix characterize nf1 neurofibroma development and response to MEK inhibitor.
Jiang C; Kumar A; Yu Z; Shipman T; Wang Y; McKay RM; Xing C; Le LQ
J Clin Invest; 2023 Jun; 133(12):. PubMed ID: 37140985
[TBL] [Abstract] [Full Text] [Related]
15. Genome-wide profiling of patient-derived glioblastoma stem-like cells reveals recurrent genetic and transcriptomic signatures associated with brain tumors.
Lazzarini E; Silvestris DA; Benvenuto G; Osti D; Fattore L; Paterra R; Finocchiaro G; Malatesta P; Daga A; Gallotti AL; Galli R; Pelicci G; Tesei A; Bedeschi M; Pallini R; Pasqualini L; Romualdi C; Gallo A; Ricci-Vitiani L; Indraccolo S
J Neurooncol; 2023 May; 163(1):47-59. PubMed ID: 37140883
[TBL] [Abstract] [Full Text] [Related]
16. Clinical, histological, and molecular features of gliomas in adults with neurofibromatosis type 1.
Romo CG; Piotrowski AF; Campian JL; Diarte J; Rodriguez FJ; Bale TA; Dahiya S; Gutmann DH; Lucas CG; Prichett L; Mellinghoff I; Blakeley JO
Neuro Oncol; 2023 Aug; 25(8):1474-1486. PubMed ID: 36840626
[TBL] [Abstract] [Full Text] [Related]
17. Malignant peripheral nerve sheath tumours in a patient with Neurofibromatosis-1.
Iqbal F; Jamaluddin M; Bukhari F; Islam OS
J Pak Med Assoc; 2023 Feb; 73(2):393-395. PubMed ID: 36800734
[TBL] [Abstract] [Full Text] [Related]
18. EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection.
Capper D; Reifenberger G; French PJ; Schweizer L; Weller M; Touat M; Niclou SP; Euskirchen P; Haberler C; Hegi ME; Brandner S; Le Rhun E; Rudà R; Sanson M; Tabatabai G; Sahm F; Wen PY; Wesseling P; Preusser M; van den Bent MJ
Neuro Oncol; 2023 May; 25(5):813-826. PubMed ID: 36632791
[TBL] [Abstract] [Full Text] [Related]
19. The cuproptosis-related signature associated with the tumor environment and prognosis of patients with glioma.
Wang W; Lu Z; Wang M; Liu Z; Wu B; Yang C; Huan H; Gong P
Front Immunol; 2022; 13():998236. PubMed ID: 36110851
[TBL] [Abstract] [Full Text] [Related]
20. MRI-guided laser interstitial thermal therapy for deep-seated gliomas in children with neurofibromatosis type 1: report of two cases.
Cross KA; Salehi A; Abdelbaki MS; Gutmann DH; Limbrick DD
Childs Nerv Syst; 2023 Mar; 39(3):787-791. PubMed ID: 36107223
[TBL] [Abstract] [Full Text] [Related]
[Next]
